Intrinsic Value of S&P & Nasdaq Contact Us

Forian Inc. FORA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
$95.65
+4348.8%
Analyst Price Target
$4.50
+109.3%

Forian Inc. (FORA) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.

The consensus price target is $4.50, representing an upside of 109.3% from the current price $2.15.

Analysts estimate Earnings Per Share (EPS) of $0.08 and revenue of $0.02B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.12 vs est $0.08 (missed -250%). 2025: actual $-0.09 vs est $-0.05 (missed -84.8%). Analyst accuracy: 0%.

FORA Stock — 12-Month Price Forecast

$4.50
▲ +109.30% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Forian Inc., the price target is $4.50.
The average price target represents a +109.30% change from the last price of $2.15.

FORA Analyst Ratings

Buy
3
Ratings
3 Buy
Based on 3 analysts giving stock ratings to Forian Inc. in the past 3 months
Rating breakdown
Buy
3 100%
100%
Buy
3 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — FORA

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.12 vs Est $0.08 ▼ 166.7% off
2025 Actual –$0.09 vs Est –$0.05 ▼ 45.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect the company to turn profitable.

Revenue Estimates — FORA

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.020B vs Est $0.020B ▲ 2.2% off
2025 Actual $0.030B vs Est $0.030B ▲ 0.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message